ACUMEN PHARMACEUTICALS INC Share Price Today: Live Updates & Key Insights

ACUMEN PHARMACEUTICALS INC share price today is $2.75, up -8.56%. The stock opened at $2.88 against the previous close of $2.92, with an intraday high of $2.935 and low of $2.665.

ACUMEN PHARMACEUTICALS INC Share Price Chart

ACUMEN PHARMACEUTICALS INC

us-stock
To Invest in {{usstockname}}
us-stock

ACUMEN PHARMACEUTICALS INC Share Price Performance

$2.75 -0.0856(-8.56%) ABOS at 23 Mar 2026 11:51 AM Biotechnology
Lowest Today 2.665
Highest Today 2.935
Today’s Open 2.88
Prev. Close 2.92
52 Week High 3.60
52 Week Low 0.86
Day’s Range: Low 2.665 High 2.935
52-Week Range: Low 0.86 High 3.60
1 day return -
1 Week return -19.51
1 month return +4.28
3 month return +19.11
6 month return +109.37
1 year return +118.77
3 year return -33.82
5 year return -86.63
10 year return -

ACUMEN PHARMACEUTICALS INC Institutional Holdings

RA Capital Management, LLC 24.65

Sands Capital Ventures, LLC 5.64

Franklin Resources Inc 3.81

FMR Inc 3.35

Vanguard Group Inc 2.73

Knollwood Investment Advisory LLC 2.69

Franklin Biotechnology Discv A(acc)USD 2.44

Fidelity Select Health Care 1.88

Vanguard Total Stock Mkt Idx Inv 1.85

Alyeska Investment Group, L.P. 1.55

ADAR1 Capital Management LLC 1.47

LAURION CAPITAL MANAGEMENT LP 1.43

Pathstone Holdings LLC 1.42

Franklin Biotechnology Discovery A 1.36

Hudson Bay Capital Management LP 1.20

Fidelity Advisor Health Care I 1.16

Millennium Management LLC 0.96

Renaissance Technologies Corp 0.70

Two Sigma Advisers, LLC 0.70

Geode Capital Management, LLC 0.68

SG Americas Securities, LLC 0.67

Susquehanna International Group, LLP 0.62

Citadel Advisors Llc 0.57

Vanguard Institutional Extnd Mkt Idx Tr 0.54

Ikarian Capital, LLC 0.44

Bank of America Corp 0.35

Fidelity VIP Health Care Initial 0.30

Fidelity Extended Market Index 0.28

iShares Micro-Cap ETF 0.17

A4Investments SICAV SIF ACCI IlanaA2EURH 0.17

Vifag 2002 SICAV 0.17

Bridgeway Ultra-Small Company Market 0.14

Bridgeway Ultra-Small Company 0.12

Blackrock Extended Mkt Fund CF 0.11

Fidelity Nasdaq Composite Index 0.11

Fidelity Total Market Index 0.10

Extended Equity Market Fund K 0.09

Spartan Extended Market Index Pool F 0.08

NT Ext Equity Mkt Idx Fd - L 0.07

Fidelity Series Total Market Index 0.07

ACUMEN PHARMACEUTICALS INC Market Status

Strong Buy: 5

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

ACUMEN PHARMACEUTICALS INC Fundamentals

Market Cap 161.73 M

PB Ratio 0.9158

PE Ratio 0.0

Enterprise Value 65.96 M

Total Assets 238.99 M

Volume 491114

ACUMEN PHARMACEUTICALS INC Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:1436000 1.4M, FY19:1697000 1.7M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:1436000 1.4M, FY19:1697000 1.7M

Annual Net worth FY23:-48740000 -48.7M, FY22:-40475000 -40.5M, FY21:-181679000 -181.7M, FY20:-7324000 -7.3M, FY19:-7862000 -7.9M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:-45000 -0.0M, Q3/2024:null 0.0M, Q2/2024:-45000 -0.0M

Quarterly Net worth Q3/2025:-26451000 -26.5M, Q2/2025:-40950000 -41.0M, Q1/2025:-28796000 -28.8M, Q3/2024:-29765000 -29.8M, Q2/2024:-20537000 -20.5M

About ACUMEN PHARMACEUTICALS INC & investment objective

Company Information Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate Sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2, which has completed the INTERCEPT-AD phase 1 clinical trial and in ALTITUDE-AD phase 2 clinical trial to target soluble amyloid-beta oligomers. It has a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of Sabirnetug. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Newton, Massachusetts.

Organisation Biotechnology

Employees 61

Industry Biotechnology

CEO Mr. Daniel J. O'Connell M.B.A.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

ACUMEN PHARMACEUTICALS INC FAQs

What is the share price of ACUMEN PHARMACEUTICALS INC today?

The current share price of ACUMEN PHARMACEUTICALS INC is $2.75.

Can I buy ACUMEN PHARMACEUTICALS INC shares in India?

Yes, Indian investors can buy ACUMEN PHARMACEUTICALS INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy ACUMEN PHARMACEUTICALS INC shares in India?

You can easily invest in ACUMEN PHARMACEUTICALS INC shares from India by:

Can I buy fractional shares of ACUMEN PHARMACEUTICALS INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of ACUMEN PHARMACEUTICALS INC?

ACUMEN PHARMACEUTICALS INC has a market cap of $161.73 M.

In which sector does ACUMEN PHARMACEUTICALS INC belong?

ACUMEN PHARMACEUTICALS INC operates in the Biotechnology sector.

What documents are required to invest in ACUMEN PHARMACEUTICALS INC stocks?

To invest, you typically need:

What is the PE and PB ratio of ACUMEN PHARMACEUTICALS INC?

The PE ratio of ACUMEN PHARMACEUTICALS INC is N/A and the PB ratio is 0.92.